This research emphasizes the importance of early diagnosis and targeted therapies for neurodegeneration in Parkinson’s disease, suggesting a personalized approach to treatment.
Parkinson's disease is a multifactorial neurodegenerative disease in which the selective neurodegeneration of dopaminergic neurons in the substantia nigra plays a key role. Current data emphasize the importance of early diagnosis and the development of disease-modifying therapies targeting the main pathogenic mechanisms. The integration of molecular, clinical, and socio-economic aspects is a promising direction for a personalized approach to treatment and improvement of patients' prognosis.
No takes yet. Share an insight, caveat, or question.
Yusupov et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: